BLFS BioLife Solutions Inc

$24.50

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending —
Expected on —
Report Time: Unknown Release Time
The Whisper Number
—
Consensus Estimate: —
Revenue Estimate: —

Latest Earnings Insight

Updated On 8/18/2025

About BioLife Solutions Inc

BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the gene and cell therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company is headquartered in Bothell, Washington.

Website: https://www.biolifesolutions.com

Sector
LIFE SCIENCES
Industry
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Exchange
NASDAQ
Country
USA
Currency
USD
Fiscal Year End
December
CIK
834365
Address
3303 MONTE VILLA PARKWAY, SUITE 310, BOTHELL, WA, US
Valuation
Market Cap
$1.04B
P/E Ratio
nan
PEG Ratio
65.38
Price to Book
2.99
Performance
EPS
$-0.25
Dividend Yield
—
Profit Margin
-24.50%
ROE
-3.32%
Technicals
50D MA
$24.85
200D MA
$24.75
52W High
$29.55
52W Low
$15.72
Fundamentals
Shares Outstanding
48M
Target Price
$31.33
Beta
1.93

BLFS EPS Estimates vs Actual

● Estimated
● Actual

BLFS News & Sentiment

Aug 15, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Zacks Industry Outlook Highlights Envista, BioLife Solutions, InfuSystems and MariMed
Despite industry headwinds, Envista, BioLife Solutions, InfuSystems and MariMed are leveraging innovation and strategy for growth.
Aug 14, 2025 • Zacks Commentary SOMEWHAT-BULLISH
4 Medical Product Stocks to Watch From a Challenging Industry
The Zacks Medical products industry sees steady demand, but tariffs & policy headwinds keep growth under pressure in 2025. NVST, BLFS, INFU and MRMD reflect the favorable fundamentals.
Aug 12, 2025 • Zacks Commentary SOMEWHAT-BULLISH
BioLife Solutions ( BLFS ) Upgraded to Strong Buy: Here's Why
BioLife Solutions (BLFS) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Aug 12, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Wall Street Analysts Predict a 39.92% Upside in BioLife Solutions ( BLFS ) : Here's What You Should Know
The mean of analysts' price targets for BioLife Solutions (BLFS) points to a 39.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Aug 07, 2025 • Zacks Commentary NEUTRAL
BioLife Solutions, Inc. ( BLFS ) Reports Break-Even Earnings for Q2
BioLife Solutions (BLFS) delivered earnings and revenue surprises of +100.00% and +6.98%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Aug 06, 2025 • Zacks Commentary NEUTRAL
MariMed Inc. ( MRMD ) Reports Break-Even Earnings for Q2
MariMed Inc. (MRMD) delivered earnings and revenue surprises of +100.00% and -2.91%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Sentiment Snapshot

Average Sentiment Score:

0.193
50 articles with scored sentiment

Overall Sentiment:

Bullish

BLFS Reported Earnings

Feb 26, 2025
Dec 31, 2024 (Pre market)
0.04 Surprise
  • Reported EPS: $-0.02
  • Estimate: $-0.06
  • Whisper: —
  • Surprise %: 71.8%
Nov 12, 2024
Sep 30, 2024 (Post market)
0.07 Surprise
  • Reported EPS: $-0.02
  • Estimate: $-0.09
  • Whisper: —
  • Surprise %: 80.6%
Aug 08, 2024
Jun 30, 2024 (Post market)
-0.36 Surprise
  • Reported EPS: $-0.50
  • Estimate: $-0.14
  • Whisper: —
  • Surprise %: -257.1%
May 09, 2024
Mar 31, 2024 (Post market)
0.05 Surprise
  • Reported EPS: $-0.23
  • Estimate: $-0.28
  • Whisper: —
  • Surprise %: 17.9%
Feb 29, 2024
Dec 31, 2023 (Post market)
0.04 Surprise
  • Reported EPS: $-0.30
  • Estimate: $-0.34
  • Whisper: —
  • Surprise %: 11.8%
Nov 09, 2023
Sep 30, 2023 (Post market)
0.07 Surprise
  • Reported EPS: $-0.30
  • Estimate: $-0.37
  • Whisper: —
  • Surprise %: 18.9%
Aug 08, 2023
Jun 30, 2023 (Post market)
-0.03 Surprise
  • Reported EPS: $-0.23
  • Estimate: $-0.20
  • Whisper: —
  • Surprise %: -15.0%
May 10, 2023
Mar 31, 2023 (Post market)
-0.11 Surprise
  • Reported EPS: $-0.32
  • Estimate: $-0.21
  • Whisper: —
  • Surprise %: -52.4%
Mar 16, 2023
Dec 31, 2022 (Post market)
-0.98 Surprise
  • Reported EPS: $-1.15
  • Estimate: $-0.17
  • Whisper: —
  • Surprise %: -576.5%

Financials